The results of this study are consistent with other research, suggesting that corticosteroids may be an effective treatment to mitigate adverse events in COVID-19 patients who exhibit heightened levels of inflammation, as indicated by CRP levels [6,23,24,25]. This evidence concerns the gene CRP and COVID-19.